Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine
Clinical trial NCT04767035 · COMPLETED
Trial details
- NCT number
- NCT04767035
- Sponsor
- Melt Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2021-01-14
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.